Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 1834
Altered Mechanotransduction via Myosin II Contributes to Collagen and IL-6 Production in Systemic Sclerosis Skin
Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2440
Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient’s Characteristics
SLE – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2111
An International Patient Survey to Identify Candidate Items for Classifying Early-Stage Symptomatic Knee Osteoarthritis
Osteoarthritis – Clinical Poster II- 10:30AM-12:30PM
-
Abstract Number: 2158
An MVPA Is MVPA Is MVPA, or Is It? Impact of the Definition of Moderate to Vigorous Physical Activity (MVPA) on Its Amount in Persons with Advanced Knee Osteoarthritis
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 1822
Analysis of Differential Activation of Lysophosphatidic Acid Regulated Genes in Diffuse and Limited Cutaneous Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Basic Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 2143
Analysis of Effectiveness and Safety of Romosozumab in Patients with Very High Risk of Fracture in a Spanish Population
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 1869
Analysis of Short-Term Side Effects Following COVID-19 Vaccination in Pregnancies Complicated by Autoimmune Inflammatory Rheumatic Diseases
Epidemiology & Public Health Poster III- 10:30AM-12:30PM
-
Abstract Number: 2126
Analysis of the Evolution of Bone Mineral Density in the Spanish Population: Results of the OsteoSER Study
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2492
ANCA Associated Tracheobronchial Disease
Vasculitis – ANCA-Associated Poster III- 10:30AM-12:30PM
-
Abstract Number: 2424
Anifrolumab Effects on Response to Influenza Vaccine in SLE
SLE – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: L13
Anifrolumab Long-Term Treatment Is More Effective Against Organ Damage Than Standard of Care Alone: Results from an External Control Arm Study on Organ Damage in Phase 3 Clinical Trials and the University of Toronto Lupus Clinic Cohort
(L01–L14) Late-Breaking Posters- 10:30AM-12:30PM
-
Abstract Number: 1776
Animal Models of Pediatric MOGAD
Pediatric Rheumatology – Basic Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2427
Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Induces Multicompartmental B Cell Depletion in Peripheral Blood, Bone Marrow and Lymph Nodes of Systemic Lupus Erythematosus
SLE – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2305
Anti-Ku Positivity in Primary Sjögren’s Disease Is Associated with a More Systemic Active Disease